Westfield Capital Management Co. LP lessened its position in Danaher Co. (NYSE:DHR) by 4.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 36,816 shares of the conglomerate’s stock after selling 1,550 shares during the period. Westfield Capital Management Co. LP’s holdings in Danaher were worth $5,262,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Next Capital Management LLC bought a new position in shares of Danaher in the second quarter worth approximately $31,000. Litman Gregory Asset Management LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $33,000. Altshuler Shaham Ltd raised its holdings in shares of Danaher by 59.3% during the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 89 shares during the last quarter. MRA Associates USA LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $40,000. Finally, Lenox Wealth Management Inc. purchased a new position in shares of Danaher during the first quarter valued at approximately $40,000. Hedge funds and other institutional investors own 78.52% of the company’s stock.

DHR stock traded up $2.24 during midday trading on Thursday, reaching $141.74. 1,851,600 shares of the company’s stock traded hands, compared to its average volume of 2,552,439. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $145.50. The stock has a market cap of $99.97 billion, a P/E ratio of 31.36, a PEG ratio of 2.52 and a beta of 0.94. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. The stock’s 50-day moving average is $140.18 and its 200 day moving average is $135.10.

Danaher (NYSE:DHR) last announced its earnings results on Thursday, July 18th. The conglomerate reported $1.19 EPS for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.04. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the prior year, the company earned $1.15 earnings per share. The firm’s revenue was up 3.5% on a year-over-year basis. As a group, research analysts expect that Danaher Co. will post 4.79 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a yield of 0.48%. Danaher’s dividend payout ratio is currently 15.04%.

Several research analysts have recently weighed in on the stock. Argus boosted their price objective on shares of Danaher to $165.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Royal Bank of Canada set a $134.00 price objective on shares of Danaher and gave the company a “hold” rating in a report on Friday, July 19th. Wolfe Research assumed coverage on shares of Danaher in a report on Thursday, May 30th. They set an “outperform” rating for the company. Robert W. Baird boosted their price objective on shares of Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a report on Friday, July 19th. Finally, Piper Jaffray Companies boosted their price objective on shares of Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a report on Thursday, July 18th. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $143.54.

In other news, Director Linda P. Hefner sold 2,601 shares of the stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $141.66, for a total value of $368,457.66. Following the completion of the sale, the director now directly owns 38,935 shares of the company’s stock, valued at $5,515,532.10. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Brian W. Ellis sold 1,010 shares of the stock in a transaction on Friday, July 26th. The stock was sold at an average price of $144.04, for a total transaction of $145,480.40. Following the completion of the sale, the insider now directly owns 20,889 shares of the company’s stock, valued at $3,008,851.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 177,202 shares of company stock valued at $25,175,829. 11.40% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: What is the Rule of 72?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.